Jump to content
  • Content Count

    121
  • Joined

  • Last visited

Clive Flashman

Administrators

Community Reputation

9 Novice

3 Followers

About Clive Flashman

  • Rank
    Junior

Profile Information

  • First name
    Clive
  • Last name
    Flashman
  • Country
    United Kingdom

About me

  • About me
    I'm leading on the development of the hub for Patient Safety Learning. I have a background in patient safety, having worked at the National Patient Safety Agency from 2002 to 2007, designing and leading the development of the NRLS. So looking forward to sharing this bold expriment with you all!!
  • Organisation
    Patient Safety Learning
  • Role
    Chief Digital Officer

Recent Profile Visitors

1,595 profile views
  1. Content Article Comment
    Hi @Derek Malyon sorry that you didn't get more traction from the AHSN, it's a tricky time at the moment but there is no excuse for being unresponsive like that. If I can think of another 'way in' I'll let you know. Kind regards, Clive
  2. News Article
    Guy’s and St Thomas’ NHS Foundation Trust will work with Omnicell to develop a European technology-enabled inventory optimisation and intelligence service which will be initially implemented across South East London Integrated Care System (ICS). This partnership will encompass all six acute hospital sites within the South East London ICS, including Guy’s & St Thomas’, Kings College Hospital NHS Foundation Trust and Lewisham & Greenwich NHS Trust. The project will have the following goals: Develop analytics and reporting tools with a goal of improving patient safety, achievin
  3. News Article
    Three quarters of patients surveyed at Jinyintan Hospital in Wuhan, China had at least one ongoing symptom The majority of people admitted to hospital with coronavirus still had symptoms six months after getting ill, a new study has revealed. Over three quarters of Covid patients surveyed at Jinyintan Hospital in Wuhan, China had at least one ongoing symptom – with the most commonly reported being fatigue or muscle weakness. A total of 1,733 patients, with a median age of 57, were examined for the study between 7 January and 29 May last year. At a follow-up, 76% of patients reported
  4. Content Article Comment
    My pleasure @Derek Malyon In the new year, I suggest you link up with your local AHSN, and have a conversation with them before sending your PDF with a covering email. I think the 'ask' needs to be as clear as possible. You would like them to trial the eQMS on x wards with y patients for z months, and then explain how the impact will be independently evaluated at the end of that.
  5. Content Article Comment
    Hi @Derek Malyon I think you need to give them a bit more info, for example: 1. Eliminate the acronyms 2. What is the purpose of the solution (in more detail) 3. Is it only for use in hospital on wards, or elsewhere? 4. Has it already been trialled in the NHS or elsewhere? If so, what were the results? 5. Have there been any academic evaluations of impact? 6. Why is it different/ better to what is already being used in the NHS? 7. How cost-effective is it? 8. the ASK - what do you want from them? What do you want them to do?
  6. Content Article Comment
    @Derek Malyon and @HelenH the typical route for innovation to enter the NHS is via the 15 regional Academic & Health Science Networks. Depending on where you are based Derek, you should make enquiries of your local AHSN to see if they can help you to promote your ideas into the NHS. If you have already tried that route then I'd be interested to hear what happened.
  7. Community Post
    Look up the Star Wards initiative - all about getting dogs onto wards as complementary therapy.
  8. Community Post
    very good example, it almost makes me think that it could be another picture category in our Error Traps gallery!!
  9. Community Post
    I have always believed that as a patient, I should own my data and that healthcare professionals are merely 'stewards' of it. I believe that legally it is owned by the Secretary of State (or at least it used to be). If I want to sell my information, I should be able to, with a highly transparent way of tracking who uses it (Blockchain or Holochain anyone?) There is an interesting company in the USA called Healix (or similar) that takes your genomic data and manages it on your behalf, only allowing other companies access to it on your behalf when you give permission, and you can revoke ac
  10. News Article
    No single solution will stop the virus’s spread, but combining different layers of public measures and personal actions can make a big difference. It’s im­por­tant to un­der­stand that a vac­cine, on its own, won’t be enough to rapidly ex­tin­guish a pan­demic as per­ni­cious as Covid-19. The pan­demic can­not be stopped through just one in­ter­ven­tion, be­cause even vac­cines are im­per­fect. Once in­tro­duced into the hu­man pop­u­la­tion, viruses con­tinue to cir­cu­late among us for a long time. Fur­ther­more, it’s likely to be as long as a year be­fore a Covid-19 vac­cine is in wide
  11. News Article
    Study finds 54 days after discharge, 69% of patients still had fatigue, and 53% were suffering from persistent breathlessness. Almost seven out of 10 patients hospitalised due to coronavirus still suffer from debilitating symptoms more than seven weeks after being discharged, according to a new study. Researchers from the University College London (UCL) division of medicine, in collaboration with with clinicians at the Royal Free London (RFL) and UCL, followed 384 patients who had tested positive and had been treated at Barnet Hospital, the Royal Free Hospital or UCLH. Collectively t
  12. News Article
    Talking Medicines, a social intelligence company for the pharmaceutical industry, has secured £1.1 million funding deal to scale up its AI-based platform for measuring patient sentiment. Tern, an investment company specialising in the Internet of Things (“IoT”), is the lead investor in a syndicated funding round alongside The Scottish Investment Bank, Scottish Enterprise’s investment arm. Led by CEO Jo Halliday alongside co-founders Dr Elizabeth Fairley and Dr Scott Crae, Talking Medicines will use the funds to support the launch and roll-out of a new AI data platform, which will tra
  13. Community Post
    I've seen a lot recently on work being done around rarer NCDs, the 'long-tail' of diagnostic go'to's. I know that a company call Volv based in Switzerland has been trying to create an AI system smart enough to bring these into the normal diagnostic process, not sure how successful they have been yet.
  14. News Article
    Researchers at UCL-led collaboration i-sense, have published a dashboard to collate data on five stages, Find, Test, Track, Isolate and Support, with an aim to provide a complete picture of the pandemic. The i-sense COVID Response Evaluation Dashboard (COVID RED) collates and presents data from the Office of National Statistics, Public Health England, and the NHS under five categories; Find, Test, Track, Isolate and Support for those asked to Isolate (FTTIS). It presents indicators of performance under each of these headings, and identifies areas where more data is needed. Co-develop
×